Status:
UNKNOWN
Atherosclerotic Lesion Proteomics by Harvesting Angioplasty Balloons (ALPHA).
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
University of Copenhagen
Herlev and Gentofte Hospital
Conditions:
Angina, Stable
Angina, Unstable
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to identify proteins, metabolites and signal pathways related directly to symptomatic atherosclerosis and to disease progression. In the study, we use residual material fro...
Eligibility Criteria
Inclusion
- Symptomatic atherosclerotic disease
- 18 years or older
- Angioplasty or vascular surgery
Exclusion
- \- Not willing or unable to give informed consent
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2024
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT05319366
Start Date
December 1 2021
End Date
July 31 2024
Last Update
April 8 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Heart Centre
Copenhagen, Denmark, 2100
2
Herlev-Gentofte
Gentofte Municipality, Denmark, 2820